Aisling Capital Management as of June 30, 2020
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 13 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 49.6 | $130M | 4.0M | 32.61 | |
| Eidos Therapeutics | 20.4 | $54M | 1.1M | 47.67 | |
| Avrobio Ord (AVRO) | 6.7 | $18M | 1.0M | 17.45 | |
| Aeglea Biotherapeutics | 6.0 | $16M | 1.7M | 9.25 | |
| Syndax Pharmaceuticals (SNDX) | 5.8 | $15M | 1.0M | 14.82 | |
| Atreca Cl A Com (BCEL) | 3.1 | $8.2M | 388k | 21.28 | |
| Obseva Sa | 3.1 | $8.2M | 1.4M | 5.89 | |
| Marker Therapeutics Ord | 1.6 | $4.1M | 2.0M | 2.07 | |
| Sunesis Pharmaceuticals Inc Ne | 1.0 | $2.7M | 10M | 0.26 | |
| Zosano Pharma Corp | 0.9 | $2.3M | 2.7M | 0.86 | |
| Verona Pharma Plc ads (VRNA) | 0.8 | $2.1M | 444k | 4.67 | |
| Nabriva Therapeutics SHS | 0.5 | $1.3M | 1.9M | 0.67 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $1.0M | 635k | 1.62 |
